[1] ALTMANN S W,DAVIS HR J R,ZHU L J,et al. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption[J]. Science,2004,303(5661):1201
[2] DAVIES J P,SCOTT C,OISHI K,et al. Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia[J]. J Biol Chem,2005,280(13):12710
[3] ZHANG J H,GE L,QI W,et al. The N-terminal domain of NPC1L1 protein binds cholesterol and plays essential roles in cholesterol uptake[J]. J Biol Chem,2011,286(28):25088
[4] TEMEL R E,TANG W,MA Y,et al. Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe[J]. J ClinInvest,2007,117(7):1968
[5] GE L,QI W,WANG L J,et al. Flotillins play an essential role in Niemann-Pick C1-like 1-mediated cholesterol uptake[J]. Proc Natl Acad Sci U S A,2011,108(2):551
[6] LI P S,FU Z Y,ZHANG Y Y,et al. The clathrin adaptor Numb regulates intestinal cholesterol absorption through dynamic interaction with NPC1L1[J]. Nat Med,2013,20(1):80
[7] WEI J,FU Z Y,LI P S,et al. Theclathrin adaptor proteins ARH,Dab2,and Numb play distinct roles in Niemann-Pick C1-Like 1 versus low density lipoprotein receptor-mediated cholesterol uptake[J]. J Biol Chem,2014,289(48):33689
[8] XIE C,LI N,CHEN Z J,et al. The small GTPase Cdc42 interacts with Niemann-Pick C1-like 1 (NPC1L1) and controls its movement from endocytic recycling compartment to plasma membrane in a cholesterol-dependent manner[J]. J Biol Chem,2011,286(41):35933
[9] ZHANG Y Y,FU Z Y,WEI J,et al. A LIMA1 variant promotes low plasma LDL cholesterol and decreases intestinal cholesterol absorption[J]. Science,2018,360(6393):1087
[10] XIE P,ZHU H,JIA L,et al. Genetic demonstration of intestinal NPC1L1 as a major determinant of hepatic cholesterol and blood atherogenic lipoprotein levels[J]. Atherosclerosis,2014,237(2):609
[11] TANG W,JIA L,MA Y,et al. Ezetimibe restores biliary cholesterol excretion in mice expressing Niemann-Pick C1-Like 1 only in liver[J]. Biochim Biophys Acta,2011,1811(9):549
[12] XIE P,JIA L,MA Y,et al. Ezetimibeinhibits hepatic Niemann-Pick C1-Like 1 to facilitate macrophage reverse cholesterol transport in mice[J]. Arterioscler Thromb Vasc Biol,2013,33(5):920
[1]刘郁莹,崔晓腾,高星杰,等.利用改良的CRISPR/Cas9基因编辑系统构建HeLa细胞SND1基因敲除稳定株[J].天津医科大学学报,2015,21(06):480.
LIU Yu-ying,CUI Xiao-teng,GAO Xing-jie,et al.Construction of HeLa SND1 knockout gene stable strain by using modified CRISPR/Cas9 gene editing system[J].Journal of Tianjin Medical University,2015,21(01):480.
[2]张 静,高 雅,李新宇,等.SUZ12过表达及敲减恶性外周神经鞘瘤稳定细胞株的建立及其意义[J].天津医科大学学报,2019,25(05):429.
ZHANG Jing,GAO Ya,LI Xin-yu,et al.Establishment and significance of SUZ12 overexpression and knockdown of stable malignant peripheral nerve sheath tumor cell lines[J].Journal of Tianjin Medical University,2019,25(01):429.
[3]张佳慧,阎晗,胡德庆.利用CRISPR/Cas9技术构建Aff4基因敲除B16-F10细胞系及AFF4的多克隆抗体制备[J].天津医科大学学报,2023,29(04):372.
ZHANG Jia-hui,YAN Han,HU De-qing.Aff4 gene knockout stable B16-F10 cell line generation with CRISPR/Cas9 system and anti-AFF4 polyclonal antibody preparation[J].Journal of Tianjin Medical University,2023,29(01):372.
[4]杨欢,冯玉梅.FOXQ1敲除乳腺癌MCF7细胞株的构建及其功能初探[J].天津医科大学学报,2023,29(05):500.
YANG Huan,FENG Yu-mei.Construction of FOXQ1 knockout MCF7 breast cancer cell line and itspreliminary functional exploration[J].Journal of Tianjin Medical University,2023,29(01):500.
[5]董玥湘,刘岩,靳小石,等.应用CRISPR/Cas9技术敲除SLC5A8基因对黑色素瘤的影响[J].天津医科大学学报,2024,30(02):128.[doi:10.20135/j.issn.1006-8147.2024.02.0128]
DONG Yuexiang,LIU Yan,JIN Xiaoshi,et al.Effect of knockdown of SLC5A8 gene on melanoma by applying CRISPR/Cas9 technology[J].Journal of Tianjin Medical University,2024,30(01):128.[doi:10.20135/j.issn.1006-8147.2024.02.0128]